Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Dolutegravir on Metformin PK in Healthy Adults
NCT02064374Phase 1Completed
- Sponsor
- ViiV Healthcare
- Start
- Feb 2014
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of dolutegravir in human immunodeficiency virus infection (HIV) (2 cohorts), sponsored by ViiV Healthcare. Primary endpoints: Steady state plasma metformin pharmacokinetics parameters at Day 22, Steady state plasma DTG PK parameters at Day 13 and 1 more. Started Feb 2014; status: completed.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02064374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02064374.